
Hotline II
Clinical Trial Update II
| Hotline II - Frontiers in interventional and device treatments | ||
![]() | ![]() | EVATEL Remote follow-up of patients implanted with an ICD Philippe Mabo, Centre Hospitalier Universitaire de Rennes, France Presentation slides | Summary slide |
![]() | ![]() | RESET Randomized Evaluation of Sirolimus-Eluting versus Everolimus-Eluting Stent Trial Takeshi Kimura, Otowa Hospital, Kyoto, Japan Presentation slides | Summary slide |
![]() | ![]() | Comparison of three-year outcomes after PCI and CABG stratified by the SYNTAX score in patients with triple-vessel coronary artery disease: An observation from the CREDO-Kyoto PCI/CABG registry cohort-2 Hiroki Shiomi, Kyoto University, Japan Presentation slides | Summary slide |
![]() | ECOST Safety of implantable cardioverter defibrillator follow-up using remote monitoring: A randomized controlled trial Salem Kacet, Hôpital Cardiologique, Lille, France Summary slide | |
![]() | EMPHASIS-HF The effect of eplerenone versus placebo on cardiovascular mortality or heart failure hospitalization in subjects with NYHA class II chronic systolic heart failure: An analysis of the High-risk groups in the study population Bertram Pitt, University of Michigan, Ann Arbor, MI Summary slide | |
| Clinical Trial Update II - Rate and rhythm | |
![]() | SMART-AV The role of electrical delay (QLV) to predict left ventricular reverse remodeling with cardiac resynchronization therapy Michael R. Gold, MD, PhD, Charleston, South Carolina Presentation slides |
![]() | PACE Biventricular pacing superior to right ventricular pacing in bradycardia patients with preserved systolic function: two-year results of PACE trial Cheuk-Man Yu, MD, FRCP, Hong Kong Presentation slides |
![]() | SHIFT-Echocardiography Selective heart rate reduction with Ivabradine improves left ventricular remodeling and function: insights from the SHIFT-Echocardiography sub-study Jean-Claude Tardif, MD, Montreal, Canada Presentation slides |

























